A £360 million package will support innovative R&D and manufacturing projects across the life sciences, automotive and aerospace sectors.
Mr Hunt announced new investments in key growth sectors, including life sciences, with a £45 million investment to fund medical research to develop new medicines for diseases like cancer, dementia and epilepsy.
According to property consultancy, Vail Williams LLP, this could indirectly boost the market in Oxford, which is home to many of the UK’s most innovative businesses in the life sciences sector.
Mike Watson, a Partner based at Vail Williams’ office in Oxford, commented: “It is heartening to see that the government recognises the importance of the UK Life Sciences sector and that knowledge workers are the engine room of the economy going forwards. The package announced today is certainly welcome and shows positive acknowledgement of that, with a likely positive impact on the life sciences sector here.”
